Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Mar 01, 2008 (Vol. 28, No. 5)

World Mapper

URL:www.sasi.group.shef.ac.uk/worldmapper/index.html
  • Effective communication tools
  • Mostly eye candy
By adulthood, we have all had at least one of those moments where something happened and, as a result, we never looked at the world the same way again. I thought of that when I discovered this unusual site. As a matter of fact, its entire focus is designed to make you look at the world totally differently. The idea here is to present quantitative information in an unorthodox manner, specifically to use information about various countries and then to scale the size of each country proportional to the magnitude of the relevant value for that country. Projected on a world map, the result will cause you to see the world differently. The advantage of this approach, as I see it, is that we are reminded in the perspectives shown of how what we do stacks up with the rest of the world. That isn’t a bad thing.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »